1. Home
  2. TCPC vs BIOA Comparison

TCPC vs BIOA Comparison

Compare TCPC & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

HOLD

Current Price

$5.89

Market Cap

449.7M

Sector

Finance

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$18.90

Market Cap

443.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCPC
BIOA
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.7M
443.9M
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
TCPC
BIOA
Price
$5.89
$18.90
Analyst Decision
Sell
Buy
Analyst Count
2
3
Target Price
$6.50
$13.50
AVG Volume (30 Days)
822.2K
779.1K
Earning Date
02-26-2026
11-06-2025
Dividend Yield
19.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$219,119,058.00
$5,917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.29
$2.88
52 Week High
$9.48
$24.00

Technical Indicators

Market Signals
Indicator
TCPC
BIOA
Relative Strength Index (RSI) 60.00 59.80
Support Level $5.65 $19.06
Resistance Level $5.90 $21.53
Average True Range (ATR) 0.14 2.22
MACD 0.05 0.24
Stochastic Oscillator 92.62 57.64

Price Performance

Historical Comparison
TCPC
BIOA

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: